Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-resistant BRAF V600E-mutant recurrent pleomorphic xanthoastrocytoma, CNS WHO Grade 3 successfully resolved with incidental discontinuation of combined BRAF and MEK inhibitor therapy.
Inoue H, Kuroda JI, Fujioka Y, Hata N, Mizoguchi M, Yoshii D, Sueyoshi H, Takeshima Y, Fujimoto K, Shinojima N, Sunami K, Mikami Y, Nakamura H, Mukasa A. Inoue H, et al. Among authors: fujioka y. Surg Neurol Int. 2024 Nov 15;15:417. doi: 10.25259/SNI_734_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 39640311 Free PMC article.
Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment.
Funakoshi Y, Hata N, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Takigawa K, Mizoguchi M. Funakoshi Y, et al. Among authors: fujioka y. Cancers (Basel). 2021 Feb 12;13(4):758. doi: 10.3390/cancers13040758. Cancers (Basel). 2021. PMID: 33673070 Free PMC article. Review.
Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.
Michiwaki Y, Hata N, Mizoguchi M, Hiwatashi A, Kuga D, Hatae R, Akagi Y, Amemiya T, Fujioka Y, Togao O, Suzuki SO, Yoshimoto K, Iwaki T, Iihara K. Michiwaki Y, et al. Among authors: fujioka y. Clin Neurol Neurosurg. 2019 Dec;187:105556. doi: 10.1016/j.clineuro.2019.105556. Epub 2019 Oct 12. Clin Neurol Neurosurg. 2019. PMID: 31639630 Free article.
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma.
Otsuji R, Hata N, Yamamoto H, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Noguchi N, Sako A, Togao O, Yoshitake T, Nakamizo A, Mizoguchi M, Yoshimoto K. Otsuji R, et al. Among authors: fujioka y. Neurooncol Adv. 2024 May 8;6(1):vdae069. doi: 10.1093/noajnl/vdae069. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39022644 Free PMC article.
706 results